"RTF is Highly Unlikely, 50/50 Probability of Approval for 9001" - Cowen Reiterates Sarepta (SRPT) at Ouperform with $114 Price Target

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. TSLA
4. NVDA
5. GNK
6. USO
7. AWK
8. AZN
9. SPCX
10. UNG

Go back to "RTF is Highly Unlikely, 50/50 Probability of Approval for 9001" - Cowen Reiterates Sarepta (SRPT) at Ouperform with $114 Price Target
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 18.20 +0.10 (0.55%)
Previous Close $18.10    52 Week High $63.73 
Open $17.93    52 Week Low $8.00 
Day High $18.30    P/E N/A 
Day Low $17.72    EPS $-5.69 
Volume 892,462